首页> 外国专利> 2-124--1--134- 2-124-TRIAZOLE-1-YL-134-THIADIAZOLE DERIVATIVES HAVING AN EFFECT ON THE C.N.S. AND THE HEART

2-124--1--134- 2-124-TRIAZOLE-1-YL-134-THIADIAZOLE DERIVATIVES HAVING AN EFFECT ON THE C.N.S. AND THE HEART

机译:2-124--1--134- 2-124-三唑-1-基-134-噻二唑衍生物对C.N.S.有影响和心

摘要

The present invention relates to novel 2-a to affect the heart and central nervous system general formula (I) (-1- 1,2,4- triazol-yl) -1,3,4-thiadiazole derivatives, and more particularly relates to a process for preparing a pharmaceutical composition, and a novel compound containing such a derivative:; Formula (I); Wherein; R 1 is from the hydrogen atom, a C 1-4 alkyl group or a halo atom, a hydroxy group, a nitro group, C 1-4 alkoxy groups, (C 1-4 alkyl) amino groups and di (C 1-4 alkyl) group consisting of amino group substituted by one to three substituents selected or unsubstituted represents an unsubstituted phenyl group; Z represents a hydrogen atom or a C 1-4 alkoxy group, R 0 has the formula Alk-NR 4 R 5 means a group and, Alk is C 1-6 means a straight or branched alkylene, and R 4 and R 5 are independently a hydrogen atom; C 2-6 alkenyl; Or it contains a hydroxy group, (C 1-4 alkyl) amino group, di (C 1-4 alkyl) amino group, 1 to 3 C 1-4 alkoxy groups and a phenyl group one or more nitrogen atoms or a nitrogen and an oxygen atom which may be substituted by and the nitrogen atom is bonded by a C 1-4 alkyl group may be substituted by or substituted by a substituent selected from the group consisting of groups of the heterocyclic saturated 5-or 6-can not be a substituted or unsubstituted C 1-8 alkyl group the display or, R 4 and R 5 together with the adjacent nitrogen atom and, optionally, one or more further nitrogen and / or oxygen and / or sulfur atoms, C 1-4 alkyl group; Or substituted by a C 1-4 alkoxy or substituted by an unsubstituted phenyl group or to form an unsubstituted saturated 5-to 10-membered heterocyclic ring, and R 2 and R 3 a group of amino group, and one of the groups group, or one or more nitrogen and / or oxygen and / or containing a sulfur atom and is bonded by a nitrogen atom, C 1-4 alkyl group, a phenyl group or a halo-substituted by a phenyl group or unsubstituted 5-to 10-membered saturated heterocyclic ring represents a group or, R 2 and R 3 a group of the formula -SR meaning, R is an alkenyl substituted or unsubstituted C 1-8 alkyl, C 2-6 by a phenyl group or a halophenyl group or groups in the formula -SR C of 2-6 alkynyl group represents the amino group, or both groups is a group consisting of C 1-6 alkyl, C 2-6 alkenyl, phenyl (C 1-4 alkyl) group or a halophenyl (C 1-4 alkyl) one or two selected from the values It is replaced by the body.
机译:本发明涉及影响心脏和中枢神经系统的新型2-a通式(I)(-1- 1,2,4-三唑基)-1,3,4-噻二唑衍生物,更特别地涉及制备药物组合物的方法,以及含有这种衍生物的新型化合物:式(I);其中R 1 来自氢原子,C 1-4 烷基或卤原子,羟基,硝基,C 1-4 < / Sub>烷氧基,(C 1-4 烷基)氨基和由被一到三个取代基取代的氨基组成的二(C 1-4 烷基)基团或未取代的表示未取代的苯基; Z代表氢原子或C 1-4 烷氧基,R 0 的分子式为Alk-NR 4 R 5 < / Sup>表示基团,Alk为C 1-6 表示直链或支链亚烷基,R 4 和R 5 独立氢原子; C 2-6 烯基;或者它包含一个羟基,(C 1-4 烷基)氨基,二(C 1-4 烷基)氨基,1至3个C 1 -4 烷氧基和苯基,一个或多个氮原子或可被取代的氮原子和氧原子,并且氮原子通过C 1-4 烷基键合可以被选自杂环饱和5-或6-的基团组成的组中的取代基取代或取代,该取代基可以不是取代的或未取代的C 1-8 烷基,或 4 和R 5 以及相邻的氮原子,以及可选的一个或多个其他氮和/或氧和/或硫原子,C 1-4 烷基;或被C 1-4 烷氧基取代或被未取代的苯基取代或形成未取代的饱和5至10元杂环,以及R 2 和R 3 一组氨基,一组基团,或一个或多个氮和/或氧,和/或含有硫原子并被氮原子键合的C 1 -4 烷基,苯基或被苯基或未被取代的5至10元饱和杂环取代的卤素表示基团,或R 2 和R 3 -SR式的基团,R是被苯基取代或未取代的C 1-8 烷基,C 2-6 2-6 炔基的-SR C卤代基团表示氨基,或两个基团均由C 1-6 烷基组成,C 2-6 烯基,苯基(C 1-4 烷基)或卤代苯基(C 1-4 烷基)一个或第二个o从值中选择它被替换为主体。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号